HLB (028300) surged to the upper price limit in early trading on the 15th, drawing investors' attention. Following two consecutive trading days of sharp declines, the short-term rebound has been equally steep.

As of 9:15 a.m. on the 15th, HLB was trading at 34,700 won, up 8,000 won (29.96%) from the previous trading day, reaching the daily price limit. The broader market was also strong at the same time, with KOSPI rising 7,273.95 (+6.08%) and KOSDAQ climbing 821.81 (+4.82%), indicating an expanding risk appetite among investors.

HLB has exhibited extreme price volatility recently. After plunging 29.89% on the 10th, it fell another 29.92% on the 13th, marking consecutive steep declines. After a partial rebound on the 14th, the stock reached the upper limit on this day, repeating a pattern of sharp surges and plunges in the short term.

HLB group stocks also showed broad strength. At the same time, HLB Pharmaceutical hit the upper limit at 8,580 won (30.00%), while HLB Life Sciences surged to 2,325 won (29.81%), HLB Therapeutics to 1,975 won (29.93%), and HLB Innovation to 11,690 won (27.06%).

However, given that HLB and its group stocks have recently demonstrated high volatility by repeatedly surging and plunging over short periods, investors need to carefully monitor relevant disclosures and changes in supply and demand before making prudent investment decisions.

[※ This article is provided as reference material for investment decisions and does not constitute a recommendation to buy or sell any specific stock. The ultimate responsibility for stock investments lies with the investor.]